Türkiye · Funded startup

Who invested in Edvido

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Advertising & Adtech

Funding summaryUpdated 26 Oct 2026

$100Kraised across 1 round since 2024, from 1 source

Latest round
Round, $100KJul 2024
Investors
2
See who backed them

The rounds

  1. Jul 2024
    Round$100K

    Source recorded

Founders and team

From Edvido's own website: 4 on the team.

  • Elif CetinkayaRegion Manager at Danone Nutricia
  • Gülin ÖzgenMarketing Director at Kingston
  • Murat SarginBoard Member at Cardiac Surgery
  • Seda YimeniciogluProduct Manager at Orzax Pharmaceuticals

Everyone who backed them

Keiretsu ForumAngel network1round
Keiretsu Forum TurkeyAngel network1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Edvido as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Alesta YatırımVC firmPer its own site

Quick answers about Edvido

Who invested in Edvido?

Edvido's investors include Keiretsu Forum and Keiretsu Forum Turkey.

How much has Edvido raised?

Edvido has raised $100K across 1 round since 2024.

When did Edvido last raise?

Edvido's most recent round was an Undisclosed round of $100K in Jul 2024.

What was Edvido's biggest round?

Its most recent round, $100K in Jul 2024, is also its largest on record.

Who backed Edvido first?

Edvido's first round on record, in Jul 2024, was backed by Keiretsu Forum and Keiretsu Forum Turkey.

What stage is Edvido at?

Edvido's latest named round is an Undisclosed round, in Jul 2024.

Where is Edvido based?

Edvido is based in Türkiye.

Companies like Edvido

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.